首页 | 官方网站   微博 | 高级检索  
     

2型糖尿病患者血清内脂素、脂联素和瘦素水平的变化
引用本文:邵挥戈,黄干.2型糖尿病患者血清内脂素、脂联素和瘦素水平的变化[J].实用预防医学,2010,17(2):220-222.
作者姓名:邵挥戈  黄干
作者单位:1. 湖南省长沙市中心医院内分泌科,湖南,长沙,410004
2. 中南大学湘雅二医院内分泌科
基金项目:国家自然科学基金中港合作项目 
摘    要:目的研究2型糖尿病(T2DM)患者血清中内脂素、脂联素和瘦素水平,为阐明T2DM的发病机制提供基础。方法将220例新诊T2DM患者和214例年龄、性别与体重指数(BMI)相匹配的健康对照组,按BMI≥25kg/m2或25kg/m2分为肥胖亚组和非肥胖亚组,采用酶联免疫吸附法(ELISA)和放射免疫法(RIA)检测其血清内脂素、脂联素和瘦素水平,并同时采用生化和化学发光法检测空腹血糖(FPG)、甘油三酯(TG)、胆固醇(Chol)以及空腹胰岛素(FINS)等。结果1.T2DM组血清内脂素、FPG、FINS、胰岛素抵抗指数(HOMA-IR)、TG、Chol水平均高于健康对照组(P0.05~0.001),而脂联素水平低于健康对照组(P0.001),瘦素在两组人群中差异无统计学意义(P0.05);2.无论是T2DM组还是健康对照组中,其肥胖亚组中的内脂素、瘦素、FINS、HOMA-IR、TG、Chol水平均高于非肥胖亚组(P0.05~0.001),而脂联素低于非肥胖亚组(P0.01~0.001);3.消除BMI因素影响的偏相关分析显示,T2DM患者血清内脂素水平仅与FPG、FINS、HOMA-IR呈正相关(r=0.267~0.443,P0.05~0.01),与脂联素呈负相关(r=-0.312,P0.05)。结论内脂素和脂联素参与了肥胖、胰岛素抵抗以及T2DM发生过程,而瘦素可能仅与肥胖状况有关,未能以独立因子作用直接参与T2DM的发生。

关 键 词:2型糖尿病  内脂素  脂联素  瘦素

Changes of Serum Visfatin,Adiponectin and Leptin Levels in Patients with Type 2 Diabetes Mellitus
SHAO Hui-ge,HUANG Can.Changes of Serum Visfatin,Adiponectin and Leptin Levels in Patients with Type 2 Diabetes Mellitus[J].Practical Preventive Medicine,2010,17(2):220-222.
Authors:SHAO Hui-ge  HUANG Can
Affiliation:SHAO Hui-ge,HUANG Gan (Department of Metabolism , Endocrinology,Changsha Central Hospital,Changsha 410004,Hunan,China)
Abstract:Objective To examine the serum levels of visfatin,adiponectin and leptin in patients with type 2 diabetes mellitus (T2DM),and to provide a basis for illustrating the pathogenesis of T2DM.Methods Two hundred and twenty patients with newly diagnosed T2DM and 214 healthy subjects matched in the age,sex,body mass index (BMI) were included in the study.They were divided into 4 subgroups according to their BMI:obese T2DM subgroup (n=135),non-obese T2DM subgroup (n=85),obese healthy subject subgroup (n=114) and no...
Keywords:Type 2 diabetes mellitus  Visfatin  Adiponectin  Leptin  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号